A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if valacyclovir (Valtrex) is a safe and effective
treatment for ano-genital HSV infections (herpes simplex virus infections of the anus and
external genitals) in HIV-infected patients.